Synbiotic Health buys exclusive rights to novel synergistic synbiotic tech

Synbiotic Health has gained the worldwide exclusive rights to Nebraska University’s novel specially-developed strains for use in formulating synergistic synbiotic products

Photo as seen on Synbiotics Health website. Bob Hutkins, Founder of SYnbiotic Health

Synbiotic Health has signed a commercial agreement with NUtech Ventures, the nonprofit technology commercialisation affiliate of the University of Nebraska. The deal grants the company worldwide exclusive rights to Nutech’s specially developed strains for use in formulating synergistic synbiotic products.

Synbiotics—combinations of probiotics and prebiotics—are a rapidly growing category of natural health products. However, researchers are only now beginning to study how synbiotics should be optimally formulated.

This licensing agreement emerged from research at the Nebraska Food for Health Center and University of Nebraska–Lincoln's department of food science and technology. The technology was developed by globally leading probiotic and prebiotic researchers, including Dr Bob Hutkins and Dr Andy Benson of the Nebraska Food for Health Center, animal scientist Dr Tom Burkey, and Dr Jens Walter from the University of Alberta.

Synbiotic Health will now be able to formulate a new generation of products in which the probiotic microbe is selectively enriched and stimulated by the paired prebiotic substrate.

To be close to the researchers, Synbiotic Health has set up its headquarters at Nebraska Innovation Campus (NIC), adjacent to the University of Nebraska-Lincoln. The office will serve as the company headquarters as its science team continues its R&D efforts on a new class of synergistic synbiotics.

A typical synbiotic is designed to deliver the separate health benefits of its constituent probiotic and prebiotic. Synbiotic Health will now be able to formulate a new generation of products in which the probiotic microbe is selectively enriched and stimulated by the paired prebiotic substrate.

>The company's first product, targeting food & beverage and nutritional supplement manufacturers, will launch in autumn 2020

The company's first product, targeting food & beverage and nutritional supplement manufacturers, will launch in autumn 2020, following its clinical programme that will commence in early 2020.

Tim Brummels, President and CEO of Synbiotic Health, said: "This strong scientific foundation allows us to develop products with demonstrated synergy between the probiotic and the prebiotic. We are confident this will make the health effects more reliable, adding value for the consumer."

Companies